Matches in SemOpenAlex for { <https://semopenalex.org/work/W2134693386> ?p ?o ?g. }
- W2134693386 endingPage "30" @default.
- W2134693386 startingPage "20" @default.
- W2134693386 abstract "BackgroundPrevious studies have demonstrated the efficacy and safety of bevacizumab in the treatment of non-small-cell lung cancer (NSCLC).MethodsSummary data from randomised trials comparing first-line bevacizumab plus platinum-based chemotherapy with chemotherapy alone for inoperable locally advanced, recurrent or metastatic NSCLC were meta-analysed. Pooled hazard ratios (HRs) for overall survival (OS) and progression-free survival (PFS), and pooled odds ratio (OR) for adverse events were calculated. The chi-squared tests evaluated interactions between treatment effects, and prognostic factors and patient characteristics.ResultsData of 2194 patients (1313 bevacizumab; 881 controls) from four phase II and III trials: AVF-0757g, JO19907, ECOG 4599 and AVAiL, were analysed. Compared with chemotherapy alone, bevacizumab significantly prolonged OS (HR 0.90; 95% confidence interval [CI] 0.81, 0.99; P=0.03), and PFS (0.72; 95% CI 0.66, 0.79; P<0.001). Bevacizumab showed a significantly greater effect on OS in patients with adenocarcinoma versus other histologies (P=0.02), and patients with body weight loss ≤5% versus >5% (P=0.03). Bevacizumab significantly increased the risk of grade ≥3 proteinuria, hypertension, haemorrhagic events, neutropenia, and febrile neutropenia.ConclusionsBevacizumab significantly prolonged OS and PFS when added to first-line platinum-based chemotherapy in patients with advanced NSCLC; no unexpected toxicity was evident." @default.
- W2134693386 created "2016-06-24" @default.
- W2134693386 creator A5006640516 @default.
- W2134693386 creator A5017396574 @default.
- W2134693386 creator A5021624793 @default.
- W2134693386 creator A5023794502 @default.
- W2134693386 creator A5026131694 @default.
- W2134693386 creator A5043053032 @default.
- W2134693386 creator A5046728958 @default.
- W2134693386 creator A5052461112 @default.
- W2134693386 creator A5058549884 @default.
- W2134693386 creator A5078389632 @default.
- W2134693386 date "2013-01-01" @default.
- W2134693386 modified "2023-10-17" @default.
- W2134693386 title "Systematic review and meta-analysis of randomised, phase II/III trials adding bevacizumab to platinum-based chemotherapy as first-line treatment in patients with advanced non-small-cell lung cancer" @default.
- W2134693386 cites W1539571840 @default.
- W2134693386 cites W1963889078 @default.
- W2134693386 cites W1977379029 @default.
- W2134693386 cites W1990737207 @default.
- W2134693386 cites W1996761484 @default.
- W2134693386 cites W1998462298 @default.
- W2134693386 cites W2007010240 @default.
- W2134693386 cites W2012368323 @default.
- W2134693386 cites W2018802677 @default.
- W2134693386 cites W2026635246 @default.
- W2134693386 cites W2029877928 @default.
- W2134693386 cites W2052335855 @default.
- W2134693386 cites W2054266161 @default.
- W2134693386 cites W2060251426 @default.
- W2134693386 cites W2060447671 @default.
- W2134693386 cites W2077129920 @default.
- W2134693386 cites W2079953288 @default.
- W2134693386 cites W2080109178 @default.
- W2134693386 cites W2096134439 @default.
- W2134693386 cites W2100327051 @default.
- W2134693386 cites W2100785570 @default.
- W2134693386 cites W2102350520 @default.
- W2134693386 cites W2103426155 @default.
- W2134693386 cites W2104504726 @default.
- W2134693386 cites W2108923852 @default.
- W2134693386 cites W2115005218 @default.
- W2134693386 cites W2115330744 @default.
- W2134693386 cites W2120959053 @default.
- W2134693386 cites W2125447919 @default.
- W2134693386 cites W2126275851 @default.
- W2134693386 cites W2126310082 @default.
- W2134693386 cites W2126930838 @default.
- W2134693386 cites W2131881867 @default.
- W2134693386 cites W2135947389 @default.
- W2134693386 cites W2138065068 @default.
- W2134693386 cites W2144660856 @default.
- W2134693386 cites W2145835533 @default.
- W2134693386 cites W2147082943 @default.
- W2134693386 cites W2153991063 @default.
- W2134693386 cites W2154581953 @default.
- W2134693386 cites W2155012968 @default.
- W2134693386 cites W2157769714 @default.
- W2134693386 cites W2160476851 @default.
- W2134693386 cites W2167224460 @default.
- W2134693386 cites W2261037082 @default.
- W2134693386 cites W2626223149 @default.
- W2134693386 cites W4242228923 @default.
- W2134693386 cites W4252851641 @default.
- W2134693386 cites W4253810722 @default.
- W2134693386 doi "https://doi.org/10.1093/annonc/mds590" @default.
- W2134693386 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23180113" @default.
- W2134693386 hasPublicationYear "2013" @default.
- W2134693386 type Work @default.
- W2134693386 sameAs 2134693386 @default.
- W2134693386 citedByCount "269" @default.
- W2134693386 countsByYear W21346933862013 @default.
- W2134693386 countsByYear W21346933862014 @default.
- W2134693386 countsByYear W21346933862015 @default.
- W2134693386 countsByYear W21346933862016 @default.
- W2134693386 countsByYear W21346933862017 @default.
- W2134693386 countsByYear W21346933862018 @default.
- W2134693386 countsByYear W21346933862019 @default.
- W2134693386 countsByYear W21346933862020 @default.
- W2134693386 countsByYear W21346933862021 @default.
- W2134693386 countsByYear W21346933862022 @default.
- W2134693386 countsByYear W21346933862023 @default.
- W2134693386 crossrefType "journal-article" @default.
- W2134693386 hasAuthorship W2134693386A5006640516 @default.
- W2134693386 hasAuthorship W2134693386A5017396574 @default.
- W2134693386 hasAuthorship W2134693386A5021624793 @default.
- W2134693386 hasAuthorship W2134693386A5023794502 @default.
- W2134693386 hasAuthorship W2134693386A5026131694 @default.
- W2134693386 hasAuthorship W2134693386A5043053032 @default.
- W2134693386 hasAuthorship W2134693386A5046728958 @default.
- W2134693386 hasAuthorship W2134693386A5052461112 @default.
- W2134693386 hasAuthorship W2134693386A5058549884 @default.
- W2134693386 hasAuthorship W2134693386A5078389632 @default.
- W2134693386 hasBestOaLocation W21346933861 @default.
- W2134693386 hasConcept C126322002 @default.
- W2134693386 hasConcept C141071460 @default.
- W2134693386 hasConcept C143998085 @default.
- W2134693386 hasConcept C197934379 @default.
- W2134693386 hasConcept C207103383 @default.